Bronchiectasis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-Tailed Opossum (Monodelphis Domestica) and North American Opossum (Didelphis Virginiana)
University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2001 Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana) Lee Anne Cope University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Animal Sciences Commons Recommended Citation Cope, Lee Anne, "Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana). " PhD diss., University of Tennessee, 2001. https://trace.tennessee.edu/utk_graddiss/2046 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Lee Anne Cope entitled "Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana)." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Animal Science. Robert W. Henry, Major Professor We have read this dissertation and recommend its acceptance: Dr. R.B. Reed, Dr. C. Mendis-Handagama, Dr. J. Schumacher, Dr. S.E. Orosz Accepted for the Council: Carolyn R. -
E Pleura and Lungs
Bailey & Love · Essential Clinical Anatomy · Bailey & Love · Essential Clinical Anatomy Essential Clinical Anatomy · Bailey & Love · Essential Clinical Anatomy · Bailey & Love Bailey & Love · Essential Clinical Anatomy · Bailey & Love · EssentialChapter Clinical4 Anatomy e pleura and lungs • The pleura ............................................................................63 • MCQs .....................................................................................75 • The lungs .............................................................................64 • USMLE MCQs ....................................................................77 • Lymphatic drainage of the thorax ..............................70 • EMQs ......................................................................................77 • Autonomic nervous system ...........................................71 • Applied questions .............................................................78 THE PLEURA reections pass laterally behind the costal margin to reach the 8th rib in the midclavicular line and the 10th rib in the The pleura is a broelastic serous membrane lined by squa- midaxillary line, and along the 12th rib and the paravertebral mous epithelium forming a sac on each side of the chest. Each line (lying over the tips of the transverse processes, about 3 pleural sac is a closed cavity invaginated by a lung. Parietal cm from the midline). pleura lines the chest wall, and visceral (pulmonary) pleura Visceral pleura has no pain bres, but the parietal pleura covers -
Clarifying the Diagnosis of Post-Inflammatory Pulmonary Fibrosis: a Population-Based Study
AGORA | RESEARCH LETTER Clarifying the diagnosis of post- inflammatory pulmonary fibrosis: a population-based study To the Editor: Epidemiological studies are important in defining the distribution and burden of diseases in a population. A common method of studying interstitial lung disease (ILD) epidemiology has been the analysis of insurance and billing claims databases, such as the Commercial Claims and Encounters Database and the Medicare Supplemental and Coordination of Benefits Database. These studies rely on the accuracy of International Statistical Classification of Diseases (ICD) codes to identify a patient population of interest. Several studies have described the incidence and prevalence of ILD by methodically searching ICD codes related to ILD or by using code-based algorithms [1–6]. Post-inflammatory pulmonary fibrosis (PPF) (ICD-9-CM 515) has been categorised as a general diagnostic code used by providers for IPF, an ILD characterised by progressive parenchymal fibrosis [1, 7]. Cases of PPF have been variably included in studies of IPF epidemiology. The prevalence of PPF may be comparable or higher to that of IPF. For example, COULTAS et al. [2] reported PPF to represent 16.7% of prevalent cases of ILDs while IPF comprised 22.5% in a population-based registry. RAGHU et al.[8] analysed a large healthcare claims database spanning the period 1996–2000 and found the prevalence of PFF to be nearly 11-fold higher than that of IPF identified by “broad case definition”. To our knowledge, however, cases designated as PPF have never been fully characterised. In particular, it is unknown to what extent PPF (ICD-9-CM 515) overlaps with the diagnosis of IPF. -
Allergic Bronchopulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis Karen Patterson1 and Mary E. Strek1 1Department of Medicine, Section of Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, Illinois Allergic bronchopulmonary aspergillosis (ABPA) is a complex clinical type of pulmonary disease that may develop in response to entity that results from an allergic immune response to Aspergillus aspergillus exposure (6) (Table 1). ABPA, one of the many fumigatus, most often occurring in a patient with asthma or cystic forms of aspergillus disease, results from a hyperreactive im- fibrosis. Sensitization to aspergillus in the allergic host leads to mune response to A. fumigatus without tissue invasion. activation of T helper 2 lymphocytes, which play a key role in ABPA occurs almost exclusively in patients with asthma or recruiting eosinophils and other inflammatory mediators. ABPA is CF who have concomitant atopy. The precise incidence of defined by a constellation of clinical, laboratory, and radiographic ABPA in patients with asthma and CF is not known but it is criteria that include active asthma, serum eosinophilia, an elevated not high. Approximately 2% of patients with asthma and 1 to total IgE level, fleeting pulmonary parenchymal opacities, bronchi- 15% of patients with CF develop ABPA (2, 4). Although the ectasis, and evidence for sensitization to Aspergillus fumigatus by incidence of ABPA has been shown to increase in some areas of skin testing. Specific diagnostic criteria exist and have evolved over the world during months when total mold counts are high, the past several decades. Staging can be helpful to distinguish active disease from remission or end-stage bronchiectasis with ABPA occurs year round, and the incidence has not been progressive destruction of lung parenchyma and loss of lung definitively shown to correlate with total ambient aspergillus function. -
Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT
diagnostics Article Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT Francesco Tiralongo 1,* , Monica Palermo 1, Giulio Distefano 1 , Ada Vancheri 2, Gianluca Sambataro 2,3 , Sebastiano Emanuele Torrisi 2, Federica Galioto 1, Agata Ferlito 1, Giulia Fazio 1, Pietro Valerio Foti 1, Letizia Antonella Mauro 1, Carlo Vancheri 2, Stefano Palmucci 1 and Antonio Basile 1 1 Radiology Unit 1, Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”—University Hospital “Policlinico-Vittorio Emanuele”, University of Catania, 95123 Catania, Italy; [email protected] (M.P.); [email protected] (G.D.); [email protected] (F.G.); [email protected] (A.F.); [email protected] (G.F.); [email protected] (P.V.F.); [email protected] (L.A.M.); [email protected] (S.P.); [email protected] (A.B.) 2 Regional Referral Centre for Rare Lung Diseases, A. O. U. “Policlinico-Vittorio Emanuele” Dept. of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (A.V.); [email protected] (G.S.); [email protected] (S.E.T.); [email protected] (C.V.) 3 Artroreuma S.R.L., Outpatient of Rheumatology associated with the National Health System, Corso S. Vito 53, 95030 Mascalucia (Catania), Italy * Correspondence: [email protected] Received: 14 April 2020; Accepted: 28 April 2020; Published: 29 April 2020 Abstract: To evaluate the radiological findings in patients with cryptogenic organizing pneumonia (COP) before steroid treatment and their behavior after therapy, we retrospectively evaluated a total of 22 patients with a diagnosis of COP made by bronchoalveolar lavage (BAL), biopsy or clinical/radiological features, and the patients were followed between 2014 and 2018 at the hospital; the demographic data, symptoms, radiologic findings, diagnostic methods and treatment plans of patients were collected from patients’ hospital records. -
Cryptogenic Organizing Pneumonia
462 Cryptogenic Organizing Pneumonia Vincent Cottin, M.D., Ph.D. 1 Jean-François Cordier, M.D. 1 1 Hospices Civils de Lyon, Louis Pradel Hospital, National Reference Address for correspondence and reprint requests Vincent Cottin, Centre for Rare Pulmonary Diseases, Competence Centre for M.D., Ph.D., Hôpital Louis Pradel, 28 avenue Doyen Lépine, F-69677 Pulmonary Hypertension, Department of Respiratory Medicine, Lyon Cedex, France (e-mail: [email protected]). University Claude Bernard Lyon I, University of Lyon, Lyon, France Semin Respir Crit Care Med 2012;33:462–475. Abstract Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of fibroblasts and myofibroblasts intermixed with loose connective matrix. This pattern is the hallmark of a clinical pathological entity, namely cryptogenic organizing pneumonia (COP) when no cause or etiologic context is found. The process of intraalveolar organization results from a sequence of alveolar injury, alveolar deposition of fibrin, and colonization of fibrin with proliferating fibroblasts. A tremen- dous challenge for research is represented by the analysis of features that differentiate the reversible process of OP from that of fibroblastic foci driving irreversible fibrosis in usual interstitial pneumonia because they may determine the different outcomes of COP and idiopathic pulmonary fibrosis (IPF), respectively. Three main imaging patterns of COP have been described: (1) multiple patchy alveolar opacities (typical pattern), (2) solitary focal nodule or mass (focal pattern), and (3) diffuse infiltrative opacities, although several other uncommon patterns have been reported, especially the reversed halo sign (atoll sign). -
Ta2, Part Iii
TERMINOLOGIA ANATOMICA Second Edition (2.06) International Anatomical Terminology FIPAT The Federative International Programme for Anatomical Terminology A programme of the International Federation of Associations of Anatomists (IFAA) TA2, PART III Contents: Systemata visceralia Visceral systems Caput V: Systema digestorium Chapter 5: Digestive system Caput VI: Systema respiratorium Chapter 6: Respiratory system Caput VII: Cavitas thoracis Chapter 7: Thoracic cavity Caput VIII: Systema urinarium Chapter 8: Urinary system Caput IX: Systemata genitalia Chapter 9: Genital systems Caput X: Cavitas abdominopelvica Chapter 10: Abdominopelvic cavity Bibliographic Reference Citation: FIPAT. Terminologia Anatomica. 2nd ed. FIPAT.library.dal.ca. Federative International Programme for Anatomical Terminology, 2019 Published pending approval by the General Assembly at the next Congress of IFAA (2019) Creative Commons License: The publication of Terminologia Anatomica is under a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license The individual terms in this terminology are within the public domain. Statements about terms being part of this international standard terminology should use the above bibliographic reference to cite this terminology. The unaltered PDF files of this terminology may be freely copied and distributed by users. IFAA member societies are authorized to publish translations of this terminology. Authors of other works that might be considered derivative should write to the Chair of FIPAT for permission to publish a derivative work. Caput V: SYSTEMA DIGESTORIUM Chapter 5: DIGESTIVE SYSTEM Latin term Latin synonym UK English US English English synonym Other 2772 Systemata visceralia Visceral systems Visceral systems Splanchnologia 2773 Systema digestorium Systema alimentarium Digestive system Digestive system Alimentary system Apparatus digestorius; Gastrointestinal system 2774 Stoma Ostium orale; Os Mouth Mouth 2775 Labia oris Lips Lips See Anatomia generalis (Ch. -
Idiopathic Pulmonary Fibrosis
IDIOPATHIC PULMONARY FIBROSIS Guidelines for Diagnosis UPDATE 2019 and Management An ATS Pocket Publication ATS Pocket Guide _v11_051319 copy.indd 1 5/13/19 10:51 AM GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF IDIOPATHIC PULMONARY FIBROSIS: UPDATE 2019 AN AMERICAN THORACIC SOCIETY POCKET PUBLICATION This pocket guide is a condensed version of the 2011, 2015 and 2018 American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Latin American Thoracic Association (ALAT) Evidence-Based Guidelines for Diagnosis and Management of Idiopathic Pulmonary Fibrosis (IPF). This pocket guide was complied by Ganesh Raghu, MD and Bridget Collins, MD, University of Washington, Seattle from excerpts taken from the published official documents of the ATS. Readers are encouraged to consult the full versions as well as the online supplements, which are available at http://ajrccm.atsjournals.org/content/183/6/788.long. All information in this pocket guide is derived from the 2011, 2015 and 2018 IPF guidelines unless otherwise noted. Some tables and figures are reprinted with the permission from the journals referenced. Produced in Collaboration with Boehringer Ingelheim Pharmaceuticals, Inc. 2 Guidelines for the Diagnosis and Management of Idiopathic Pulmonary Fibrosis ATS Pocket Guide _v11_051319 copy.indd 2 5/13/19 10:51 AM CONTENTS List of Figures and Tables ..................................................................................................................4 List of Abbreviations and Acronyms -
A Case of Cryptogenic Organizing Pneumonia in a Patient with Idiopathic Thrombocytopenic Purpura
J Case Rep Images Med 2017;3:39–41. De Giorgi et al. 39 www.edoriumjournals.com/case-reports/jcrm CASE REPORT PEER REVIEWED OPEN| OPEN ACCESS ACCESS A case of cryptogenic organizing pneumonia in a patient with idiopathic thrombocytopenic purpura Alfredo De Giorgi, Marco Fiore, Federico Moro, Michele Domenico Spampinato, Fabio Fabbian ABSTRACT with corticosteroids obtaining progressive improvement of thrombocytopenia and Introduction: Cryptogenic organized pulmonary distress. Conclusion: Association pneumonia (COP) or bronchiolitis obliterans- between ITP and COP or BOOP could be ascribed organizing pneumonia (BOOP) is clinical to autoimmune derangement. Respiratory condition characterized by interstitial lung symptoms and imaging in patients with ITP disease with loss of functioning parenchyma could suggest association with COP or BOOP. due to inflammatory damage and pulmonary However, both conditions might ameliorate fibrosis. We report a case of COP related with corticosteroid treatment. to autoimmune condition in patients with idiopathic thrombocytopenic purpura (ITP) Keywords: Atoll sign, Bronchiolitis obliterans-or- and diabetes mellitus type 1. Case Report: A ganizing pneumonia, Cryptogenic organized pneu- 46-year-old deaf and mute male was admitted monia, Idiopathic thrombocytopenic purpura to our hospital for general sickness, severe dyspnea. He had a history of ITP started 20 How to cite this article years before, previous splenectomy, smoking, systemic hypertension, diabetes mellitus De Giorgi A, Fiore M, Moro F, Spampinato MD, type 1, glaucoma, previous admission for Fabbian F. A case of cryptogenic organizing pulmonary thromboembolism. High resolution pneumonia in a patient with idiopathic computed tomography (HRCT) found diffuse thrombocytopenic purpura. J Case Rep Images Med interstitial thickening with a bilateral ground- 2017;3:39–41. -
Structure of the Respiratory System: Lungs, Airways and Dead Space 1
Structure of the respiratory system: lungs, 1 airways and dead space (a) Lung lobes RU (b) The airways LU RM RL LL Nasal cavity Right lateral Left lateral Pharynx aspect aspect Epiglotti s Larynx C6 Cricoi d C 7 Sternal angl e T 1 (angle of Louis) T2 RU Tr achea (generation 0) T 3 LU Manubrium T 4 Carina RM T 5 RL R and L main bronchi (generation 1) LL Body T 6 Anterior aspect Bronchi (generations 2–11) T 7 Sternum Bronchioles (gener ations 12–16) T 8 T 9 Respiratory bronchioles (generations 17–19) Xiphoi d T 10 LU RU process Alveolar ducts and sacs Diaphragm T 11 (generations 20–23) RU = Right upper RM = Right middl e T 12 LL RL RL = Right lowe r LU = Left upper LL = Left lowe r Posterior aspect (c) Bohr equation for measuring Anatomical dead space, End-tidal = dead space Vo lume = V alveolar gas D In an expired breath none of the CO 2 expi re d came from the dead space region Anatomical dead space, Mixed expired gas: Vo lume = V ; ∴ Vo lume = V D T Quantity of CO2 Mixed expired CO2 fraction = FECO2 in mixed expired air = quantity of CO 2 from alveolar region Respiratory zone: V x F CO = (V –V ) x F CO Alveolar CO 2 fraction = FACO2 T E 2 T D A 2 ∴ VD = V T (F ACO2– F ECO2)/ FACO2 CO - free gas CO - containing gas End of inspira tion 2 2 End of expira tion 10 Structure and function Lungs, airways and dead space WWTR01.inddTR01.indd 1100 224/5/20064/5/2006 110:33:340:33:34 Lungs increased numbers more than make up for their reduced size. -
Surgical Pathology of Non-Neoplastic Lung Disease Thomas V
SHORT COURSE Surgical Pathology of Non-Neoplastic Lung Disease Thomas V. Colby, M.D. Department of Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona At inception, this course included some neoplastic Case 1: Acute Exacerbation of Idiopathic lesions, but each year, the case mix was changed in Pulmonary Fibrosis response to the comments (and criticism) of the A 51-year-old man had experienced 3 to 4 years attendees. As cases were added and deleted, in the of progressive dyspnea and interstitial infiltrates as end only examples of non-neoplastic lung disease observed on chest radiographs. One week before were discussed. Of the 19 cases used during the death, there was acute worsening of his dyspnea, course of 5 years, the following 8 were selected for with some associated chills and a sore throat. At this presentation. admission, he was hypoxemic, tachypneic, and afe- brile. The clinical impression was an acute (possibly CASES 1, 2, AND 3: IDIOPATHIC INTERSTITIAL infectious) process superimposed on idiopathic PNEUMONIAS AND RELATED LESIONS pulmonary fibrosis (IPF). An open-lung biopsy was performed. The patient died 1 week later. Cultures To the clinician, there are well over 100 causes of and special stains were negative. interstitial pneumonia, but among these, there is a select subgroup that has been called the idiopathic Histologic findings interstitial pneumonias. This group has evolved The open biopsy shows subpleural scarring and from Liebow and Carrington’s (1) classic classifica- microscopic honeycombing, with associated tion of chronic interstitial pneumonias: smooth muscle metaplasia and fibroblastic foci Usual interstitial pneumonia (UIP) (Figs. 1 and 2). -
Sildenafil Acutely Reverses the Hypoxic Pulmonary
0031-3998/08/6403-0251 Vol. 64, No. 3, 2008 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2008 International Pediatric Research Foundation, Inc. Sildenafil Acutely Reverses the Hypoxic Pulmonary Vasoconstriction Response of the Newborn Pig ROGERIO TESSLER, SHENGPING WU, RENATO FIORI, CHRISTOPHER K. MACGOWAN, AND JAQUES BELIK Departments of Pediatrics [J.B.], Medical Biophysics and Medical Imaging [S.W., C.K.M.], University of Toronto, Toronto, Ontario, Canada M5G 1X8; Department of Pediatrics [R.T.], Pontifı´cia Universidade Cato´lica do Rio Grande do Sul, Rio Grande do Sul, Brazil, 90680000 ABSTRACT: Sildenafil is a pulmonary vasodilator shown to be nary hypertension (9) and worsening of arterial oxygenation has effective in neonates, but conflicting data exist regarding its effect on been reported in animal models of this disease (10–12). As such, arterial oxygenation. To address this issue, we tested the sildenafil it has been suggested that sildenafil inhibits the hypoxic pulmo- effect on the piglet’s hypoxic pulmonary vasoconstriction (HPV) nary vasoconstrictor (HPV) response leading to increased blood response. A segmental lung atelectasis was created by obstructing the flow to nonventilated lung units (10). This speculative mecha- corresponding bronchus. Total pulmonary and specific flows to the nism has never been properly evaluated. atelectatic and contra-lateral lobes were measured by magnetic res- onance (MR) before and 30-min post sildenafil (0.2 and 1 mg/kg i.v.) Little is known about the HPV response in the newborn. When or saline administration. Flow was reduced (p Ͻ 0.01) in the atelec- compared with the adult animal data, the HPV response is tatic and increased in the contra-lateral lobe indicating an effective reduced early in life in sheep and rabbits (13–15), but after HPV response.